.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Cantor Fitzgerald
Johnson and Johnson
Harvard Business School
Merck
Fuji
Baxter
Cipla
Healthtrust
QuintilesIMS

Generated: September 25, 2017

DrugPatentWatch Database Preview

NALTREXONE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Naltrexone Hydrochloride, and when can generic versions of Naltrexone Hydrochloride launch?

Naltrexone Hydrochloride is a drug marketed by Accord Hlthcare, Apotex Inc, Barr, Sandoz, Sun Pharma Global, Mallinckrodt, and Elite Labs. and is included in seven NDAs.

The generic ingredient in NALTREXONE HYDROCHLORIDE is naltrexone hydrochloride. There are eighteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the naltrexone hydrochloride profile page.

Summary for Tradename: NALTREXONE HYDROCHLORIDE

Patents:0
Applicants:7
NDAs:7
Suppliers / Packagers: see list13
Bulk Api Vendors: see list42
Clinical Trials: see list2,582
Patent Applications: see list557
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NALTREXONE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: NALTREXONE HYDROCHLORIDE

Drug ClassOpioid Antagonist
Mechanism of ActionOpioid Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare
NALTREXONE HYDROCHLORIDE
naltrexone hydrochloride
TABLET;ORAL091205-001Aug 17, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt
NALTREXONE HYDROCHLORIDE
naltrexone hydrochloride
TABLET;ORAL076264-002Mar 22, 2002ABRXNoYes► Subscribe► Subscribe► Subscribe
Sandoz
NALTREXONE HYDROCHLORIDE
naltrexone hydrochloride
TABLET;ORAL075434-001Mar 8, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt
NALTREXONE HYDROCHLORIDE
naltrexone hydrochloride
TABLET;ORAL076264-003Mar 22, 2002RXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
NALTREXONE HYDROCHLORIDE
naltrexone hydrochloride
TABLET;ORAL207905-001Jul 21, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Barr
NALTREXONE HYDROCHLORIDE
naltrexone hydrochloride
TABLET;ORAL074918-001May 8, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt
NALTREXONE HYDROCHLORIDE
naltrexone hydrochloride
TABLET;ORAL076264-001Mar 22, 2002RXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
NALTREXONE HYDROCHLORIDE
naltrexone hydrochloride
TABLET;ORAL090356-001Feb 24, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Elite Labs
NALTREXONE HYDROCHLORIDE
naltrexone hydrochloride
TABLET;ORAL075274-001May 26, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Merck
Argus Health
Julphar
Daiichi Sankyo
Fish and Richardson
Dow
Chinese Patent Office
UBS
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot